Northwest Biotherapeutics Inc (NWBO)

OTC Markets
0.644
0.000(0.00%)
After Hours
0.640
-0.004(-0.621%)
- Delayed Data
  • Volume:
    2,035,639
  • Bid/Ask:
    0.000/0.000
  • Day's Range:
    0.620 - 0.670

NWBO Overview

Prev. Close
0.644
Day's Range
0.62-0.67
Revenue
1.23M
Open
0.625
52 wk Range
0.41-2.03
EPS
0.143
Volume
2,035,639
Market Cap
663.83M
Dividend (Yield)
N/A
(N/A)
Average Vol. (3m)
1,773,410
P/E Ratio
-9.22
Beta
0.166
1-Year Change
-44%
Shares Outstanding
1,037,230,618
Next Earnings Date
-
What is your sentiment on Northwest Biotherapeutics?
or
Market is currently closed. Voting is open during market hours.

Northwest Biotherapeutics Inc News

Welcome to Your News Upgrade

Be the First to Know and Act on Market Moving News.

Welcome to Your News Upgrade

Northwest Biotherapeutics Inc Analysis

Northwest Biotherapeutics Inc Company Profile

Northwest Biotherapeutics Inc Company Profile

Employees
0

Northwest Biotherapeutics, Inc. is a biotechnology company. The Company is focused on developing personalized immune therapies for cancer. It has developed a platform technology, DCVax, which uses activated dendritic cells to mobilize a patient's own immune system to attack their cancer. The Company's product line includes DCVax-L and DCVax-Direct. DCVax-L is designed to treat solid tumor cancers in which the tumors can be surgically removed. It has completed a 331-patient international Phase III trial of DCVax-L for Glioblastoma multiforme brain cancer (GBM). DCVax-Direct, is designed to treat inoperable solid tumors. A 40-patient Phase I trial has been completed and included treatment of a diverse range of more than a dozen types of cancers. Its wholly owned subsidiaries include Flaskworks, Aracaris Ltd, Aracaris Capital, Ltd, Northwest Biotherapeutics B.V., and NW Bio GmbH.

Read More

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesStrong BuyStrong BuySellSellStrong Sell
Technical IndicatorsStrong BuyBuySellStrong SellStrong Sell
SummaryStrong BuyStrong BuySellStrong SellStrong Sell
  • is this it? Is NWBO finally gathering momentum?
    0
    • For everyone person selling there is one person buying, so the short term fluctuations are either manipulative or based on an indiviiduals cash flow requirements because anyone selling now, must really need the money.
      0
      • I'm still very positve on this stock. Recent price increases are justifiable. I think some good news is just slowly getting out, so as to not breach insider trading regs. Purely specualtive but this company has a lot going for it and have made enough signficant advancements to show the ethical intent to grow the company. I just bought more shares as did my research partner.
        0
        • The company has a compassionate use approval.
          0
          • Northwest Biotherapeutics Announces Commencement Of Cancer Vaccine Production At Its Sawston, UK Facility
            0
            • Many people think either an aquisition or joint venture will occur. It's takes a lot of courage and moneytary support to go something with this much potential on their own. Anybody heard any credable rumors?
              0
              • With all the evidence this company has a strong future, I'm supprised more investors haven't figured it out. Maybe to much reading and time to figure it out.
                0
                • News ??
                  0
                  • I remain bullish on test results holding 33k @.17 so its been an interesting ride...Hope the best is yet to come for investors but more importantly patients
                    0
                    • Did anyone ever tell you, you look like the politician from Florida.
                      0
                    • I ran against Jack Tobin in 1992.
                      0
                    • Skip Robinson Oh my Jack Tobin...blast from the past
                      0
                  • hopefully soon!
                    0